Month: July 2025

Phase 4 Drilling Set to Advance Mineralization at KAP Project CALGARY, Alberta, July 28, 2025 (GLOBE NEWSWIRE) — Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce that mobilization has commenced for the 2025 summer diamond drilling campaign at the Company’s wholly owned KAP Project (“KAP”), located in the Northwest Territories (“NWT”). The Phase 4 drilling program will consist of approximately 1,000 metres of diamond drilling over a 25-day period and will target the expansion and delineation of prospective gallium and zinc mineralization at the Main Showing. This marks the first modern drill campaign at KAP, following encouraging historical results and recent technical reinterpretations. GeoCraft Geological Services Corp. (“GeoCraft“) has been retained as...

HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD) today announced that it will release the financial results for its three months ended June 30, 2025, on Tuesday, August 5, 2025, at 7:00 a.m. C.D.T. A conference call with the Company will be held the same day at 9:00 a.m. C.D.T. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will be given a unique PIN to gain immediate access to the call. Pre-registration may be completed at any time up to the call start time. To pre-register, go to https://register-conf.media-server.com/register/BI5eaab857a8e3428387524df1ea5a519c The live call and replay can also be heard at https://edge.media-server.com/mmc/p/e9ususwz or on the Company’s website, www.gldd.com,...

ST. LOUIS, July 28, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its groundbreaking MAGiC Sweep™ catheter. MAGiC Sweep is the world’s first robotically navigated high-density electrophysiology (EP) mapping catheter, representing a significant advancement in the technology available to diagnose and treat complex arrhythmia patients. High density mapping has transformed the EP field, enhancing cardiac ablation procedures by enabling more efficient, detailed and precise identification of arrhythmia origin. The combination of high-density mapping with robotics is designed to offer multiple improvements:Efficient High-Density...

BURNABY, British Columbia, July 28, 2025 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today that it recently closed an early renewal and extension of its revolving credit facility with its syndicate of major Canadian and U.S. banks. The commitment amount under the facility was renewed at approximately C$560 million, and the maturity of the facility has been extended from December 2026 to July 2029. The renewal includes several improved provisions that will enhance the Company’s financial flexibility, including a higher threshold as to when a minimum EBITDA interest coverage ratio covenant may apply. In addition, Interfor also renewed its private shelf note purchase agreement with PGIM Inc., the principal asset management business of Prudential Financial. The shelf note purchase agreement...

MONTREAL, July 28, 2025 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland” or the “Corporation”) (TSX-V: MD) is pleased to announce the closing of a previously announced private placement (see press release dated July 22, 2025), for gross proceeds of $5,058,750 from the sale of 10,650,000 shares of the Corporation (each a “FT Share”) at a price of $0.475 per FT Share. Each FT Share will qualify as a “flow-through share” within the meaning of subsection 66(15) of the Income Tax Act (Canada) (“Tax Act”). As part of the private placement, Midland is pleased to welcome Centerra Gold Inc. (“Centerra”) (TSX: CG) (NYSE: CGAU) as a new strategic investor. Centerra now holds approximately 9.9% of the Corporation’s issued and outstanding common shares. Midland is also pleased to announce the closing of a concurrent non-brokered private...

– ATH434 Demonstrated Clinical Benefit on the Unified MSA Rating Scale and Global Measures of Neurological Symptoms – – Neuroimaging Biomarkers Showed Target Engagement and Slowed Brain Atrophy – – ATH434 was Well-Tolerated with Favorable Safety Profile – – Data are Consistent with Phase 2 Double-Blind Trial and Support Advancement of ATH434 in MSA – MELBOURNE, Australia and SAN FRANCISCO, July 28, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced positive topline data from the ATH434-202 open-label Phase 2 clinical trial in individuals with multiple system atrophy (MSA). The ATH434-202 trial evaluated a patient population with more advanced disease than...

OMAHA, Neb., July 28, 2025 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”), a leading self-custodial cryptocurrency platform, today announced that it will provide a business update and release its second quarter financial results on Monday, August 11, 2025, after market close. An earnings conference webcast will be held at 4:30 PM ET on the same day. To access the webcast, please use this link. It will also be available on the Company’s website www.exodus.com. Supplementary materials will also be made available prior to the webcast on the “Investor Relations” portion of the Company website. About Exodus Exodus is a financial technology leader empowering individuals and businesses with secure, user-friendly crypto software solutions. Since 2015, Exodus has made digital assets accessible to everyone...

CEDAR PARK, Texas, July 28, 2025 (GLOBE NEWSWIRE) — Firefly Aerospace, a market leading space and defense technology company, today announced that it has launched the roadshow for its proposed initial public offering of 16,200,000 shares of its common stock. In addition, Firefly intends to grant the underwriters a 30-day option to purchase an additional 2,430,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $35.00 and $39.00 per share. Firefly intends to use its net proceeds from this offering to repay outstanding borrowings under its credit agreement, pay any accrued and unpaid dividends on certain series of its preferred stock, and for general corporate purposes. Firefly has applied to list its common...